CNV
Clinical trials for CNV explained in plain language.
Never miss a new study
Get alerted when new CNV trials appear
Sign up with your email to follow new studies for CNV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot gene therapy aims to free patients from monthly eye injections
Disease control Recruiting nowThis study is testing a one-time gene therapy called RGX-314 for people with wet age-related macular degeneration (wet AMD), a leading cause of vision loss. The goal is to see if this single treatment can help the eye make its own medicine to control the disease, potentially redu…
Matched conditions: CNV
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Apr 01, 2026 22:47 UTC
-
One-Shot gene therapy could end decades of eye injections for millions
Disease control Recruiting nowThis study is testing a one-time gene therapy called RGX-314 for people with wet age-related macular degeneration (wet AMD), a leading cause of vision loss. The goal is to see if this single treatment can help control the disease long-term, potentially freeing patients from the b…
Matched conditions: CNV
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC